Senior MSL, Multiple Myeloma — Oncology Field Leader

AbbVie; Washington (District of Columbia); Sur place; USD 125 000 - 237 000; Plein temps

Avantages offerts par ce poste

Paid time off

Medical/dental/vision insurance

401(k) retirement plan

Résumé du poste

AbbVie is seeking a high-impact MSL/Senior MSL in Oncology (Multiple Myeloma) covering the Mid-Atlantic region. This field-based scientist will strategically support research and business objectives across the product life cycle and build relationships with healthcare professionals.

Responsibilities include delivering scientific education, supporting research initiatives, collaborating with cross-functional teams, and ensuring compliant medical communications while traveling up to 75% within

Qualifications

• Advanced degree in a health science field; Doctorate preferred.
• 3 years minimum experience for Senior MSL in oncology or related area.
• Excellent communication and ability to translate complex data.

Responsabilités

• Identify and maintain relationships with thought leaders and researchers.
• Present scientific information on disease state and AbbVie products.
• Support research initiatives and investigator meetings.
• Collaborate with cross-functional teams to develop account plans.
• Provide medical/scientific education to healthcare professionals.
• Travel up to 75% within the territory; ensure compliant activities.

Connaissances

Excel

Word

PowerPoint

Verbal communication

Written communication

Presentation skills

Formation

Advanced degree (PharmD/MD/PhD)

3+ years Senior MSL experience

Description du poste

AbbVie is seeking a high-impact MSL/Senior MSL in Oncology (Multiple Myeloma) covering the Mid-Atlantic region. This field-based scientist will strategically support research and business objectives across the product life cycle and build relationships with healthcare professionals.

Responsibilities include delivering scientific education, supporting research initiatives, collaborating with cross-functional teams, and ensuring compliant medical communications while traveling up to 75% within